Albert is the man. Waiting/Hoping for a surprise with accelerated approval QuafFlu, and Elderly approval and revenue for 2017/2018.
....a disgusting and nauseating plunge in the first half hour trading was likely a coordinated attack by Hedge Funds that then triggered the HFT robot computers resulting in a sudden avalanche of selling. Positive Phase 3 Elderly results will finally put an end to all of the shenanigans. And that can't get here soon enough.
Well said. The carnage in NVAX is shocking, but if you believe in the science(which has been hugely derisked through numerous clinical successes) you take the pain and ride it out to Phase 3 Elderly results. If positive, NVAX will be significantly higher regardless of the state of the economy or stock market.
...unlikely. We're stuck here until we get closer to Elderly results unless they announce accelerated approval for QuadFlu(whatever happened to that?) or fast track for elderly.
...NVAX needs to update this with some positive news to stop the train wreck that is going on. More slides and Glenn talking about how maternal immunization is an "elegant" way to immunize isn't going to stop the massive destruction in shareholder value that has occurred. While the execution has been flawless, NVAX needs to wake up and learn how to manage Wall Street. Stan waxing poetic ain't going to do it. Accelerated Approval, Fast Track or a partnership for International distribution will.
...down almost 25%. As bad as it can get with no apparent negative news.
...hard to believe still going lower.
If I hear Glenn talk again about maternal immunization being "elegant" I'm going to puke. With the stock price at 52 week lows, there is nothing elegant going on.
If that was the case, given the many presentations over the past year, why is the stock in the dumpster?
...now you're starting to sound like an idiot pumper. NVAX has been crushed with other small cap Biotechs, unfortunately even more so. The Morgan conference is not going to do anything in this environment unless they announce accelerated approval for QuadFlu or Fast Track for Elderly. Otherwise, it is just more of the same, which has not prevented the devastation in the share price.
...it's like they never existed.
...game changer for the stock if it is.
As I've stated before, you're simply an idiot. Now, like the other 3 Horseman on this board, I rightfully put you on ignore
I'm a neophyte here, but I'm surprised some of the smarter minds on this board haven't attempted to extrapolate the numbers for Elderly. It seems simple - 60+ Million elderly currently in the US, and expected to grow to 80 Million by 2020. Approx. $150.00+ per injection. So if they penetrate 33% to 50% of the market you're at $3 Billion plus. What would be considered peak population penetration of this vaccine - 50%, 60%, 70% of the elderly population?
you left out the 2 largest potential catalysts between now and 3rd Quarter data - possible accelerated approval for QuadFlu, and fast track for Elderly. Either would be a huge boost for the stock.
Otherwise we bump around between $7 and $9 until we get closer to Elderly results.